Alger Jason bought HCAT
February 25, 2026 · Form 4 insider transaction
Alger Jason bought 22,222 shares of Health Catalyst, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
22,222
Price
$0.00
Total value
N/A
InsiderAlger Jason
RoleOfficer
CompanyHealth Catalyst, Inc. (HCAT)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateFebruary 25, 2026
Filing dateFebruary 27, 2026
Shares owned after776,136
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents an award of 22,222 performance-based restricted units ("PRSUs") pursuant to the 2019 Plan, based upon the Issuer's satisfaction of certain performance criteria for the fiscal year ended December 31, 2025. Each PRSU represents a contingent right to receive one share of the Issuer's common stock.